Search Results for "Frontotemporal Lobar Degeneration"
Original Source: Estimating the Number of Persons with Frontotemporal Lobar Degeneration in the US Population.
There are many challenges for determining the prevalence and incidence of frontotemporal lobar degenerations (FTLD). Consequently, the number of cases of behavioral variant frontotemporal dementia (bvFTD) or primary progressive aphasia (PPA) in the USA is unknown. Our objective was to derive a consensus estimate of bvFTD and PPA prevalence and thereby to estimate the total number of these syndromes in the USA. We identified five prevalence and three incidence studies of FTLD based on passive surveillance an...
Matching Channels
AgeRelated Macular Degeneration AMD or ARMD
Macular degeneration in the elderly (AMD) is a major cause of blindness. Its prevalence increases to 30% in patients 75 to 85 years of age. AMD occurs in two forms: dry and wet AMD. Central geograph...
The interaction of complement C5a and its receptor for the treatment of inflammatory diseases include rheumatoid arthritis, systemic lupus erythematosus, asthma, wet age-related macular degeneration...
Caspases are a family of enzymes with very specific characteristics that can be used in almost every biological pathway in the body. The knock-on effects of the action of caspases keep us alive, ini...
Matching News
Rapamycin can alleviate frontotemporal lobar degeneration
A southern Taiwan-based National Cheng Kung University (NCKU) research team has discovered that rapamycin, a drug as a autophagy activator is a possible treatment to alleviating frontotemporal lobar d...
Is It Alzheimer's Or Another Dementia? MRI Scan Can Tell
Doctors will find it easier to tell whether a patient has Alzheimer's disease or another kind of dementia with a new method of using MRI scans, researchers from Perelman School of Medicine and Frontot...
MRI can screen patients for Alzheimer's disease or frontotemporal lobar degeneration
When trying to determine the root cause of a person's dementia, using an MRI can effectively and non-invasively screen patients for Alzheimer's disease or Frontotemporal Lobar Degeneration (FTLD), acc...
Scientists identify enigmatic aggregates linked to neurodegenerative diseases
The proteins that have now been identified shouldn't actually exist. Nevertheless, they build the core of cellular aggregates whose identity has been enigmatic until now. These aggregates are typicall...
New model of tau pathology spread
Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs)...
MRI could serve as lumbar puncture proxy
Structural brain patterns on magnetic resonance imaging predict cerebrospinal fluid biomarker levels in patients with suspected Alzheimer’s disease or frontotemporal lobar degeneration, preliminary...
Memantine treatment showed no benefit in patients with FTD. These data do not support memantine use in FTD.
Matching PubMed Articles
An algorithm for genetic testing of frontotemporal lobar degeneration.
To derive an algorithm for genetic testing of patients with frontotemporal lobar degeneration (FTLD).
White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration.
To evaluate the distribution of white matter (WM) disease in frontotemporal lobar degeneration (FTLD) and Alzheimer disease (AD) and to evaluate the relative usefulness of WM and gray matter (GM) for...
In a genome-wide association study of frontotemporal lobar degeneration with pathological inclusions of TAR DNA-binding protein, significant association was obtained with three single nucleotide polym...
Aim: The behavioral and psychological symptoms of dementia place a heavy burden on caregivers. Antipsychotic drugs, though used to reduce the symptoms, frequently decrease patients' activities of d...
